ASCF–III will focus on secured credit transactions for operating and holding companies, with a few investments in hybrid structures tailored to deal requirements. Aiming for a gross portfolio IRR of 16%-18%, the sector-agnostic fund will invest in industries such as pharmaceuticals, healthcare, manufacturing, consumer, chemicals, technology, and B2B businesses.
